Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

A Novel Platform for Detection of CK+ and CK− CTCs

Open access
Pecot, Chad V., Bischoff, Farideh Z., Mayer, Julie Ann, Wong, Karina L., Pham, Tam, Bottsford-Miller, Justin, Stone, Rebecca L., Lin, Yvonne G., Jaladurgam, Padmavathi, Roh, Ju Won, Goodman, Blake W., Merritt, William M., Pircher, Tony J., Mikolajczyk, Stephen D., Nick, Alpa M., Celestino, Joseph, Eng, Cathy, Ellis, Lee M., Deavers, Michael T., Sood, Anil K.·2011·Cancer Discovery

Abstract

Metastasis is a complex, multistep process that begins with the epithelial–mesenchymal transition (EMT). Circulating tumor cells (CTC) are believed to have undergone EMT and thus lack or express low levels of epithelial markers commonly used for enrichment and/or detection of such cells. However, most current CTC detection methods target only EpCAM and/or cytokeratin (CK) to enrich epithelial CTCs, resulting in failure to recognize other, perhaps more important, CTC phenotypes that lack expression of these markers. Here, we describe a population of complex aneuploid CTCs that do not express CK or CD45 antigen in patients with breast, ovarian, or colorectal cancer. These cells were not observed in healthy subjects. We show that the primary epithelial tumors were characterized by similar complex aneuploidy, indicating conversion to an EMT phenotype in the captured cells. Collectively, our study provides a new method for highly efficient capture of previously unrecognized populations of CTCs. Significance: Current assays for CTC capture likely miss populations of cells that have undergone EMT. Capture and study of CTCs that have undergone EMT would allow a better understanding of the mechanisms driving metastasis. Cancer Discovery; 1(7); 580–86. ©2011 AACR. This article is highlighted in the In This Issue feature, p. 539

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-11-0215

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 217

Metadata

Authors
Pecot, C. V., Bischoff, F. Z., Mayer, J. A., Wong, K. L., Pham, T., Bottsford-Miller, J., Stone, R. L., Lin, Y. G., Jaladurgam, P., Roh, J. W., Goodman, B. W., Merritt, W. M., Pircher, T. J., Mikolajczyk, S. D., Nick, A. M., Celestino, J., Eng, C., Ellis, L. M., Deavers, M. T., & Sood, A. K.
Venue
Cancer Discovery
Published
2011-12-01
Volume
1
Issue
7
Pages
580-586
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2139511888
Cited by
217
References
4
FWCI
7.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Novel Platform for Detection of CK+ and CK− CTCs. https://app.cochat.ai/papers/10.1158/2159-8290.cd-11-0215
The paper
Pecot, C. V., Bischoff, F. Z., Mayer, J. A., Wong, K. L., Pham, T., Bottsford-Miller, J., Stone, R. L., Lin, Y. G., Jaladurgam, P., Roh, J. W., Goodman, B. W., Merritt, W. M., Pircher, T. J., Mikolajczyk, S. D., Nick, A. M., Celestino, J., Eng, C., Ellis, L. M., Deavers, M. T., & Sood, A. K. (2011). A Novel Platform for Detection of CK+ and CK− CTCs. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-11-0215

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.